Macrogenics AACR 2022 Poster MGC018 Preclinical Proof of Concept MGC018 Prostate Cancer

MacroGenics Inc. published this content on March 21, 2022, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 23, 2025 at 16:16 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]